A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers

NCT01177150 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-28431754/ Placebo
DRUG: JNJ-28431754

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.